What is CytomX Therapeutics's capex?

CytomX Therapeutics (CTMX) reported capex of $0 in Q1 2026.

How has CytomX Therapeutics's capex changed year-over-year?

CytomX Therapeutics's capex decreased by 100.0% year-over-year, from $119K to $0.

What is the long-term trend for CytomX Therapeutics's capex?

Over 3 years (2021 to 2024), CytomX Therapeutics's capex has grown at a -42.2% compound annual growth rate (CAGR), from $1.61M to $310K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

CytomX Therapeutics CTMX CapEx

CapEx at other companies

PfizerPFE

$436M-22.7%

AmgenAMGN

$712M+73.2%

Janux TherapeuticsJANX

$273K-26.4%

Allogene TherapeuticsALLO

$9K-90.9%

Vor BiopharmaVOR

$48K-79.2%

Design Therapeutics, Inc.DSGN

$0-100%

Other financials

Income statement

See full

Revenue$10.3M-79.9%

Operating income-$19.7M-187%

Net income-$18.2M-178%

EPS (diluted)-$0.10-137%

Balance sheet

See full

Cash & equivalents$28.8M-39.4%

Total debt$2.9M-65.0%

Total equity$319.9M+1,177%

Total assets$359.4M+265%

Cash flow

See full

Operating cash flow-$25.5M-21.4%

Free cash flow-$25.5M-20.7%

Valuation

See full

Market cap$711.89M+94.8%

Enterprise value$685.92M+110%

P/S20×+17.6×

Profitability

See full

Operating margin-181.9%-206pp

Net margin-166.4%-195pp

FCF margin-225.6%-334pp

Returns & leverage

See full

Return on equity-34.3%—

Debt / equity0×-0.3×

Current ratio10.4×+8.7×

Where this comes from

Reported directly by CytomX Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CytomX Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CytomX Therapeutics's capex?: CytomX Therapeutics (CTMX) reported capex of $0 in Q1 2026.
How has CytomX Therapeutics's capex changed year-over-year?: CytomX Therapeutics's capex decreased by 100.0% year-over-year, from $119K to $0.
What is the long-term trend for CytomX Therapeutics's capex?: Over 3 years (2021 to 2024), CytomX Therapeutics's capex has grown at a -42.2% compound annual growth rate (CAGR), from $1.61M to $310K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.